Table 1 Baseline characteristics of the study population stratified by tertiles of MHR value
|  | Total (n = 34,335) | MHR | P | ||
|---|---|---|---|---|---|
< 0.009 (n = 11,537) | 0.009–0.013 (n = 11,400) | > 0.013 (n = 11,398) | |||
MHR | 0.012 ± 0.006 | 0.006 ± 0.001 | 0.011 ± 0.001 | 0.018 ± 0.007 | < 0.001 |
Age, year | 49.6 ± 18.2 | 49.7 ± 17.7 | 49.1 ± 18.3 | 50.0 ± 18.6 | < 0.001 |
Male, n (%) | 16,601 (48.4%) | 3671 (31.8%) | 5527 (48.5%) | 7403 (64.9%) | < 0.001 |
Ethnicity, n (%) | < 0.001 | ||||
 Mexican American | 6187 (18.0%) | 1809 (15.7%) | 2274 (19.9%) | 2104 (18.5%) |  |
 Non-Hispanic White | 16,133 (47.0%) | 4846 (42.0%) | 5266 (46.2%) | 6021 (52.8%) |  |
 Non-Hispanic Black | 6691 (19.5%) | 2982 (25.8%) | 2116 (18.6%) | 1593 (14.0%) |  |
 Others | 5324 (15.5%) | 1900 (16.5%) | 1744 (15.3%) | 1680 (14.7%) |  |
Smoker, n (%) | 15,975 (46.5%) | 4490 (38.9%) | 5209 (45.7%) | 6276 (55.1%) | < 0.001 |
Drinker, n (%) | 24,198 (70.5%) | 7918 (68.6%) | 8018 (70.3%) | 8262 (72.5%) | < 0.001 |
Diabetes mellitus, n (%) | 24,198 (70.5%) | 911 (7.9%) | 1327 (11.6%) | 1640 (14.4%) | < 0.001 |
Hypertension, n (%) | 11,722 (34.1%) | 3524 (30.5%) | 3849 (33.8%) | 4349 (38.2%) | < 0.001 |
Heart failure, n (%) | 1093 (3.2%) | 235 (2.0%) | 308 (2.7%) | 550 (4.8%) | < 0.001 |
Coronary heart disease, n (%) | 1450 (4.2%) | 250 (2.2%) | 479 (4.2%) | 721 (6.3%) | < 0.001 |
Stroke, n (%) | 1240 (3.6%) | 335 (2.9%) | 389 (3.4%) | 516 (4.5%) | < 0.001 |
Cancer, n (%) | 3078 (9.0%) | 1013 (8.8%) | 972 (8.5%) | 1093 (9.6%) | 0.013 |
Body mass index, kg/m2 | 28.8 ± 6.6 | 27.2 ± 6.4 | 28.9 ± 6.5 | 30.2 ± 6.6 | < 0.001 |
White blood cell,103/μL | 7.24 ± 2.42 | 6.15 ± 1.74 | 7.14 ± 1.83 | 8.45 ± 2.92 | < 0.001 |
Monocyte,103/μL | 0.55 ± 0.20 | 0.41 ± 0.11 | 0.54 ± 0.12 | 0.72 ± 0.22 | < 0.001 |
Hemoglobin, g/dL | 14.13 ± 1.54 | 13.75 ± 1.41 | 14.14 ± 1.53 | 14.52 ± 1.60 | < 0.001 |
Platelets, 103/μL | 252.31 ± 67.30 | 246.32 ± 65.60 | 252.31 ± 65.59 | 258.37 ± 70.11 | < 0.001 |
Triglyceride, mg/dL | 139.89 ± 106.77 | 106.29 ± 66.54 | 136.13 ± 92.17 | 177.66 ± 137.04 | < 0.001 |
LDL-C, mg/dL | 117.05 ± 36.14 | 116.08 ± 35.44 | 117.46 ± 36.24 | 117.61 ± 36.71 | 0.002 |
HDL-C, mg/dL | 52.54 ± 15.85 | 64.83 ± 16.03 | 51.66 ± 11.05 | 40.98 ± 9.34 | < 0.001 |
Albumin, g/dL | 4.25 ± 0.35 | 4.26 ± 0.36 | 4.25 ± 0.35 | 4.25 ± 0.35 | 0.038 |
eGFR, mL/min/1.73 m2 | 95.13 ± 32.75 | 95.30 ± 33.43 | 96.05 ± 32.25 | 94.05 ± 32.52 | < 0.001 |
All-cause mortality, n (%) | 4310 (12.6%) | 1181 (10.2%) | 1328 (11.7%) | 1801 (15.8%) | < 0.001 |
Cardiovascular mortality, n (%) | 754 (2.2%) | 165 (1.4%) | 247 (2.2%) | 342 (3.0%) | < 0.001 |